The $11.35M insider sell cluster is too small relative to Medpace's $16.7B market cap to warrant a bearish read. CEO Troendle's sales are likely part of a routine diversification plan. Monitor the next 10-Q for any operational deterioration, but this filing alone does not signal material negative information.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 14 $578.50entry
- T+1 · 3mo ago +3.22%α +3.69% · $597.12
- T+5 · 3mo ago +7.30%α +8.67% · $620.75
- T+20 · 2mo ago +2.92%α +4.91% · $595.41
- T+60 · 8d ago +16.32%α +19.37% · $672.93
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Medpace CEO August Troendle and a director sold a combined $11.35M in open-market sales over two days, with the CEO alone accounting for $10.66M. At a $16.7B market cap, these sales represent ~0.07% of market cap, below the 0.1% materiality threshold, and are likely routine diversification or tax-planning moves, not a bearish signal. The cluster is a sell-only event with no buys, but the dollar amount is trivial relative to company size, and the CEO's sales follow a pattern consistent with periodic liquidity needs rather than informed selling.
Key Financial Metrics
Key Facts
- CEO August Troendle sold 17,610 shares at $605.11 on 2026-08-11, totaling $10.66M
- Director Cornelius McCarthy sold 1,140 shares at $605.37 on 2026-08-11, totaling $690K
- Total cluster value of $11.35M represents ~0.07% of Medpace's $16.7B market cap
- No insider purchases in the cluster; all transactions are open-market sales (code S)
- Recent 30-day insider activity shows 7 prior sells totaling $24.0M, consistent with ongoing selling pattern
Financial Impact
Total insider sales of $11.35M, representing ~0.07% of market cap, immaterial relative to company size
Risk Factors
- CEO selling pattern could accelerate if fundamentals weaken
- Insider sales may continue as part of pre-arranged 10b5-1 plans
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-MEDP-1786691799581 |
Track record
24 reports on MEDP
5 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +11.09% at T+20 after the Dec 4, 2025 report. 5 of 6 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $652.28 Now $648.20 +0.62% settles Nov 17
- Nov 13, 20263d ago SC 13G Neutral 4/10 Entry $653.94 to $648.20 Now $648.20 −0.88% ▼ −0.88% +1.03% vs SPY
- Nov 2, 202614d ago Insider Cluster Bearish 4/10 Entry $663.49 to $656.77 Now $648.20 +2.30% ▲ +1.01% +2.66% vs SPY
- Oct 29, 202618d ago 144 Neutral 2/10 Entry $677.56 to $652.01 Now $648.20 −4.33% ▼ −3.77% −2.00% vs SPY
- Oct 27, 202620d ago 144 Neutral 2/10 Entry $673.79 to $692.68 Now $648.20 −3.80% ▲ +2.80% +2.46% vs SPY
- Oct 26, 202621d ago 144 Neutral 2/10 Entry $673.79 to $692.68 Now $648.20 −3.80% ▲ +2.80% +2.46% vs SPY
- Oct 23, 202624d ago Institutional Cluster Bullish 4/10 Entry $669.20 to $676.77 Now $648.20 −3.14% ▲ +1.13% +0.42% vs SPY
- Oct 21, 202626d ago 8-K Bullish 6/10 Entry $653.96 to $669.20 Now $648.20 −0.88% ▲ +2.33% +2.85% vs SPY
- Sep 28, 20267w ago SC 13D/A Neutral 4/10 Entry $622.11 to $624.18 Now $648.20 +4.19% ▲ +0.33% +0.54% vs SPY
- Aug 31, 202611w ago Insider Cluster Neutral 2/10 Entry $583.21 to $593.02 Now $648.20 +11.14% ▲ +1.68% +1.24% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers